{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:50:18Z","timestamp":1784033418061,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The identification of novel therapeutic targets in triple negative breast cancer (TNBC) continues to be of paramount importance. In this context, ADH1A (Alcohol Dehydrogenase 1\u00a0A), a protein involved in tyrosine metabolism, was comprehensively examined to assess its expression and functional roles in TNBC. A combination of bioinformatics approaches and local tissue analyses was utilized to determine the expression levels of ADH1A in TNBC samples. Genetic manipulation techniques were employed to alter ADH1A expression, and the subsequent effects on TNBC cell behavior were systematically analyzed. This study is the first to report on the alterations of 14 genes related to tyrosine metabolism within the TCGA-TNBC cohorts. Notably, reduced expression of these enzymes is associated with poorer survival outcomes in patients with TNBC. An analysis of the TCGA database revealed reduced levels of ADH1A in human TNBC tissues. Furthermore, ADH1A protein expression was diminished in TNBC tissues of patients who received local treatment, in contrast to the elevated expression observed in adjacent normal tissues. In the MDA-MB-231 and SUM159PT cell lines, ADH1A knockdown significantly promoted cell proliferation, migration, and invasion. On the contrary, ADH1A overexpression inhibited cell proliferation, migration, and invasion, while inducing cell apoptosis. Mechanistically, the overexpression of ADH1A may attenuate the malignant characteristics of TNBC cells by inhibiting the Wnt\/\u03b2-catenin signaling pathway. In conclusion, ADH1A may be a useful biomarker for TNBC prognosis. This study is the first to reveal that ADH1A inhibits the malignant progression of TNBC via the Wnt\/\u03b2-catenin signaling pathway.<\/jats:p>","DOI":"10.1038\/s41598-025-17643-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:48:04Z","timestamp":1758883684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overexpression of alcohol dehydrogenase 1\u00a0A inhibits the progress of triple negative breast cancer via Wnt\/\u03b2-catenin signaling"],"prefix":"10.1038","volume":"15","author":[{"given":"Lihong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"17643_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and future burden of breast cancer: global statistics for 2020 and 2040 [J]. Breast 66, 15\u201323 (2022).","journal-title":"Breast"},{"issue":"1","key":"17643_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer [J]. Nat. Reviews Disease Primers. 5 (1), 66 (2019).","journal-title":"Nat. Reviews Disease Primers"},{"key":"17643_CR3","doi-asserted-by":"crossref","unstructured":"Vagia, E., Mahalingam, D. & Cristofanilli, M. The landscape of targeted therapies in TNBC [J]. Cancers (Basel) 12(4), 916 (2020).","DOI":"10.3390\/cancers12040916"},{"issue":"1","key":"17643_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1055-9965.EPI-14-0980","volume":"24","author":"T Wiggins","year":"2015","unstructured":"Wiggins, T. et al. Tyrosine, phenylalanine, and Tryptophan in gastroesophageal malignancy: a systematic review [J]. Cancer Epidemiol. Biomarkers Prev. 24 (1), 32\u201338 (2015).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"17643_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semcancer.2005.04.003","volume":"15","author":"HS Lai","year":"2005","unstructured":"Lai, H. S. et al. Plasma free amino acid profile in cancer patients [J]. Semin Cancer Biol. 15 (4), 267\u2013276 (2005).","journal-title":"Semin Cancer Biol."},{"key":"17643_CR6","doi-asserted-by":"publisher","first-page":"994259","DOI":"10.3389\/fimmu.2022.994259","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma [J]. Front. Immunol. 13, 994259 (2022).","journal-title":"Front. Immunol."},{"issue":"5","key":"17643_CR7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.81939","volume":"19","author":"W Tian","year":"2023","unstructured":"Tian, W. et al. Novel implication of the basement membrane for breast cancer outcome and immune infiltration [J]. Int. J. Biol. Sci. 19 (5), 1645\u20131663 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"17643_CR8","doi-asserted-by":"crossref","unstructured":"Tian, W. et al. Autophagy deficiency induced by SAT1 potentiates tumor progression in Triple-Negative breast cancer [J]. Adv Sci (Weinh). 11 (36), e2309903 (2024).","DOI":"10.1002\/advs.202309903"},{"issue":"D1","key":"17643_CR9","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M. et al. KEGG as a reference resource for gene and protein annotation [J]. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"17643_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes [J]. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"17643_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.4316","volume":"232","author":"S Marastoni","year":"2014","unstructured":"Marastoni, S. et al. EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration [J]. J. Pathol. 232 (4), 391\u2013404 (2014).","journal-title":"J. Pathol."},{"issue":"11","key":"17643_CR12","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1111\/cas.13771","volume":"109","author":"P Yin","year":"2018","unstructured":"Yin, P. et al. Wnt signaling in human and mouse breast cancer: focusing on Wnt ligands, receptors and antagonists [J]. Cancer Sci. 109 (11), 3368\u20133375 (2018).","journal-title":"Cancer Sci."},{"issue":"10","key":"17643_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/humu.23047","volume":"37","author":"PR Blackburn","year":"2016","unstructured":"Blackburn, P. R. et al. Silent tyrosinemia type I without elevated tyrosine or succinylacetone associated with liver cirrhosis and hepatocellular carcinoma [J]. Hum. Mutat. 37 (10), 1097\u20131105 (2016).","journal-title":"Hum. Mutat."},{"issue":"6","key":"17643_CR14","doi-asserted-by":"publisher","first-page":"e0229276","DOI":"10.1371\/journal.pone.0229276","volume":"15","author":"TN Nguyen","year":"2020","unstructured":"Nguyen, T. N., Nguyen, H. Q. & Le, D. H. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses [J]. PloS One. 15 (6), e0229276 (2020).","journal-title":"PloS One"},{"key":"17643_CR15","doi-asserted-by":"crossref","unstructured":"De Matteis, S. et al. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities [J]. Oxidative medicine and cellular longevity\u00a02018, 7512159 (2018).","DOI":"10.1155\/2018\/7512159"},{"key":"17643_CR16","doi-asserted-by":"crossref","unstructured":"Li, W. et al. Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer [J]. J. Oncol. 2022, 5504173 (2022).","DOI":"10.1155\/2022\/5504173"},{"key":"17643_CR17","doi-asserted-by":"publisher","first-page":"115545","DOI":"10.1016\/j.bcp.2023.115545","volume":"212","author":"AM Karim","year":"2023","unstructured":"Karim, A. M. et al. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies [J]. Biochem. Pharmacol. 212, 115545 (2023).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"17643_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Recent advances in therapeutic strategies for triple-negative breast cancer [J]. J. Hematol. Oncol. 15 (1), 121 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"17643_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2013.07.066","volume":"529","author":"Y Bouyacoub","year":"2013","unstructured":"Bouyacoub, Y. et al. Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome [J]. Gene 529 (1), 45\u201349 (2013).","journal-title":"Gene"},{"issue":"11","key":"17643_CR20","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1074\/jbc.M116.764787","volume":"292","author":"L Li","year":"2017","unstructured":"Li, L. et al. Fumarylacetoacetate hydrolase Knock-out rabbit model for hereditary tyrosinemia type 1 [J]. J. Biol. Chem. 292 (11), 4755\u20134763 (2017).","journal-title":"J. Biol. Chem."},{"key":"17643_CR21","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Decreased SLC27A5 suppresses lipid synthesis and tyrosine metabolism to activate the cell cycle in hepatocellular carcinoma [J]. Biomedicines. 10(2),234 (2022).","DOI":"10.3390\/biomedicines10020234"},{"issue":"5","key":"17643_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer [J]. Free Radic Res. 44 (5), 479\u2013496 (2010).","journal-title":"Free Radic Res."},{"issue":"1","key":"17643_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02255973","volume":"8","author":"JO H\u00f6\u00f6g","year":"2001","unstructured":"H\u00f6\u00f6g, J. O. et al. Mammalian alcohol dehydrogenase - functional and structural implications [J]. J. Biomed. Sci. 8 (1), 71\u201376 (2001).","journal-title":"J. Biomed. Sci."},{"key":"17643_CR24","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fonc.2019.01000","volume":"9","author":"KR Zahid","year":"2019","unstructured":"Zahid, K. R. et al. mTOR\/HDAC1 crosstalk mediated suppression of ADH1A and ALDH2 links alcohol metabolism to hepatocellular carcinoma onset and progression in Silico [J]. Front. Oncol. 9, 1000 (2019).","journal-title":"Front. Oncol."},{"key":"17643_CR25","doi-asserted-by":"crossref","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-Related hepatocellular carcinoma [J]. Cell. 179(2), 561\u2009\u2013\u2009577 (2019).","DOI":"10.1016\/j.cell.2019.08.052"},{"issue":"1","key":"17643_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1186\/s12885-020-07689-1","volume":"20","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma [J]. BMC Cancer. 20 (1), 1204 (2020).","journal-title":"BMC Cancer"},{"key":"17643_CR27","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.2147\/JIR.S452670","volume":"17","author":"J Ma","year":"2024","unstructured":"Ma, J. et al. Inflammation-Related gene ADH1A regulates the polarization of macrophage M1 and influences the malignant progression of gastric cancer [J]. J. Inflamm. Res. 17, 4647\u20134665 (2024).","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"17643_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N. & boutros, M. Wnt signaling in cancer [J]. Oncogene. 36 (11), 1461\u20131473 (2017).","journal-title":"Oncogene"},{"issue":"12","key":"17643_CR29","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1038\/emboj.2012.124","volume":"31","author":"C Niehrs","year":"2012","unstructured":"Niehrs, C. & Acebron, S. P. Mitotic and mitogenic Wnt signalling [J]. Embo J. 31 (12), 2705\u20132713 (2012).","journal-title":"Embo J."},{"key":"17643_CR30","doi-asserted-by":"publisher","first-page":"705384","DOI":"10.3389\/fonc.2021.705384","volume":"11","author":"WA De Abreu","year":"2021","unstructured":"De Abreu, W. A. et al. Wnt\/\u03b2-Catenin Inhibition disrupts carboplatin resistance in isogenic models of Triple-Negative breast cancer [J]. Front. Oncol. 11, 705384 (2021).","journal-title":"Front. Oncol."},{"issue":"2","key":"17643_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ajmg.b.30990","volume":"153b","author":"L Zuo","year":"2010","unstructured":"Zuo, L. et al. ADH1A variation predisposes to personality traits and substance dependence [J]. Am. J. Med. Genet. B Neuropsychiatr Genet. 153b (2), 376\u2013386 (2010).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17643-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:48:10Z","timestamp":1758883690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17643-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17643-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32986"}}